Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
NCT ID: NCT04068844
Last Updated: 2025-01-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
93 participants
INTERVENTIONAL
2019-08-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Abnormal Vascular, Metabolic, and Neural Function During Exercise in Heart Failure With Preserved Ejection Fraction
NCT03465072
Mechanisms and Management of Exercise Intolerance in Older Heart Failure Patients
NCT03111017
Tailored Exercise Training Study Among Adults With HFpEF
NCT07223242
Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease
NCT01418248
Exercise Intolerance in Elderly Patients With HFpEF(Heart Failure With Preserved Ejection Fraction)
NCT02636439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Central HFpEF whole body exercise
HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to whole body cycle training.
Exercise training
Exercise training, either whole body or isolated single leg
Central HFpEF isolated single leg exercise
HFpEF patients who have a central limitation as the cause of the exercise intolerance randomized to isolated single leg training.
Exercise training
Exercise training, either whole body or isolated single leg
Peripheral HFpEF whole body exercise
HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to whole body cycle training.
Exercise training
Exercise training, either whole body or isolated single leg
Peripheral HFpEF isolated single leg exercise
HFpEF patients who have a peripheral limitation as the cause of the exercise intolerance randomized to isolated single leg training.
Exercise training
Exercise training, either whole body or isolated single leg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise training
Exercise training, either whole body or isolated single leg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* an ejection fraction \> 0.50
* objective evidence of diastolic dysfunction
Exclusion Criteria
* BMI \> 50 kg/m2
* PDE5 inhibitor use
* Severe valvular disease
* Severe COPD
* CKD 4 or higher
* Contra-indication to MRI.
60 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas at Arlington
OTHER
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin Levine
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Institute for Exercise and Environmental Medicine
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Leahy MG, Wakeham DJ, MacNamara JP, Brazile T, Abulimiti A, Hearon CM Jr, Samels M, Tomlinson AR, Balmain BN, Babb TG, Levine BD, Sarma S. Heart-Lung Interactions in HFpEF: Dynamic Hyperinflation and Exercise PCWP. JACC Heart Fail. 2025 Aug;13(8):102523. doi: 10.1016/j.jchf.2025.102523. Epub 2025 Jun 26.
Skow RJ, Sarma S, MacNamara JP, Bartlett MF, Wakeham DJ, Martin ZT, Samels M, Nandadeva D, Brazile TL, Ren J, Fu Q, Babb TG, Balmain BN, Nelson MD, Hynan LS, Levine BD, Fadel PJ, Haykowsky MJ, Hearon CM Jr. Identifying the Mechanisms of a Peripherally Limited Exercise Phenotype in Patients With Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2024 Aug;17(8):e011693. doi: 10.1161/CIRCHEARTFAILURE.123.011693. Epub 2024 Jul 25.
Sarma S, MacNamara JP, Balmain BN, Hearon CM Jr, Wakeham DJ, Tomlinson AR, Hynan LS, Babb TG, Levine BD. Challenging the Hemodynamic Hypothesis in Heart Failure With Preserved Ejection Fraction: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure? Circulation. 2023 Jan 31;147(5):378-387. doi: 10.1161/CIRCULATIONAHA.122.061828. Epub 2022 Dec 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU-2019-0617
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.